newheader.jpg

Search CHI's Network

 

Roche Pays $56.5M for Therapeutic Human Polyclonals, Inc.

April 2, 2007--Roche has paid $56.5 million to acquire Therapeutic Human Polyclonals, Inc. (THP), which is based in California and Germany. Roche plans to fully integrate THP into the Roche Pharma Center of Excellence for Protein Research in Penzberg, Germany. Roche

 

foot.jpg


Cambridge Healthtech Institute| Beyond Genome | Bio-IT World | Biomarker World Congress | Digital Healthcare & Productivity |
 Discovery On Target | Bio-IT World Conference & Expo  | Insight Pharma Reports | Molecular Medicine Tri-Conference | PEGS
PepTalk
| Pharma WeekWorld Pharmaceutical Congress

Your  Life Science Network

Cambridge Healthtech Institute  |  250 First Avenue  |  Suite 300   |   Needham,  MA  02494
Phone: 781-972-5400  |   Fax: 781-972-5425
chi@healthtech.com